​

Revvity (RVTY) Stock Forecast, Price Target & Predictions

OverviewRevenueFinancialsChartTranscripts

RVTY Stock Forecast

Revvity (RVTY) stock forecast, based on 28 Wall Street analysts, predicts a 12-month average price target of $135.00, with a high of $140.00 and a low of $130.00. This represents a 41.07% increase from the last price of $95.70.

$95 $104 $113 $122 $131 $140 High: $140 Avg: $135 Low: $130 Last Closed Price: $95.7

RVTY Stock Rating

Revvity stock's rating consensus is Buy, based on 28 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 17 Buy (60.71%), 11 Hold (39.29%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 28 0 11 17 Strong Sell Sell Hold Buy Strong Buy

RVTY Price Target Upside V Benchmarks

TypeNameUpside
StockRevvity41.07%
SectorHealthcare Stocks 24.81%
IndustryDiagnostics & Research Stocks22.17%

Price Target Trends

1M3M12M
# Anlaysts--9
Avg Price Target--$129.44
Last Closing Price$95.70$95.70$95.70
Upside/Downside--35.26%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jun, 253107--20
May, 254106--20
Apr, 25497--20
Mar, 25587--20
Feb, 25587--20
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jan 21, 2025Andrew CooperRaymond James$140.00$116.6020.07%46.29%
Jan 10, 2025Eve BursteinBernstein$130.00$113.8814.16%35.84%
Nov 04, 2024Paul KnightKeyBanc$132.00$124.825.75%37.93%
Oct 15, 2024Luke SergottBarclays$140.00$122.9113.90%46.29%
Jul 30, 2024Derik de BruinBank of America Securities$127.00$125.591.12%32.71%
Jul 29, 2024Tycho PetersonJefferies$125.00$125.29-0.23%30.62%
Jul 29, 2024Daniel AriasStifel Nicolaus$110.00$120.16-8.46%14.94%
Jul 29, 2024Vijay KumarEvercore ISI$126.00$120.164.86%31.66%
Jul 29, 2024Patrick DonnellyCitigroup$135.00$120.1612.35%41.07%
Apr 29, 2024Dan LeonardUBS$120.00$105.0214.26%25.39%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
May 01, 2025UBSNeutralBuyupgrade
Feb 03, 2025KeyBancOverweightOverweighthold
Feb 03, 2025BarclaysOverweightOverweighthold
Jan 21, 2025Raymond JamesOutperformOutperformhold
Jan 10, 2025BernsteinMarket Performdowngrade
Nov 04, 2024KeyBancOverweightOverweighthold
Oct 15, 2024BarclaysEqual-WeightOverweightupgrade
Aug 27, 2024Wells FargoEqual-Weightinitialise
Jul 30, 2024Cowen & Co.BuyBuyhold
Jul 30, 2024BarclaysEqual-WeightEqual-Weighthold

Financial Forecast

EPS Forecast

$2 $4 $6 $8 $10 $12 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$6.53$8.12$4.51$5.56$2.30----
Avg Forecast$7.36$11.04$7.78$4.56$4.85$4.98$5.59$6.21$6.64
High Forecast$7.41$11.12$7.86$4.59$4.87$5.18$5.91$6.32$6.76
Low Forecast$7.27$10.90$7.63$4.54$4.79$4.87$4.91$6.12$6.54
Surprise %-11.28%-26.45%-42.03%21.93%-52.58%----

Revenue Forecast

$3B $3B $4B $4B $5B $6B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$3.78B$5.07B$3.31B$2.75B$2.76B----
Avg Forecast$3.65B$4.98B$4.59B$2.73B$2.75B$2.86B$3.05B$3.23B$3.30B
High Forecast$3.67B$5.00B$4.63B$2.74B$2.79B$2.89B$3.06B$3.25B$3.34B
Low Forecast$3.62B$4.93B$4.52B$2.70B$2.74B$2.83B$3.04B$3.21B$3.26B
Surprise %3.53%1.83%-27.83%0.68%0.04%----

Net Income Forecast

$0 $300M $600M $900M $1B $2B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$727.89M$943.16M$569.18M$693.09M$270.38M----
Avg Forecast$918.64M$1.38B$971.53M$569.72M$602.42M$627.36M$675.00M$776.55M$828.50M
High Forecast$925.45M$1.39B$981.56M$572.85M$607.42M$646.75M$737.60M$789.41M$843.15M
Low Forecast$906.94M$1.36B$952.74M$566.60M$597.43M$607.97M$612.39M$763.68M$815.67M
Surprise %-20.77%-31.54%-41.41%21.65%-55.12%----

RVTY Forecast FAQ

Is Revvity stock a buy?

Revvity stock has a consensus rating of Buy, based on 28 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 17 Buy, 11 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Revvity is a favorable investment for most analysts.

What is Revvity's price target?

Revvity's price target, set by 28 Wall Street analysts, averages $135 over the next 12 months. The price target range spans from $130 at the low end to $140 at the high end, suggesting a potential 41.07% change from the previous closing price of $95.7.

How does Revvity stock forecast compare to its benchmarks?

Revvity's stock forecast shows a 41.07% upside, outperforming the average forecast for the healthcare stocks sector (24.81%) and outperforming the diagnostics & research stocks industry (22.17%).

What is the breakdown of analyst ratings for Revvity over the past three months?

  • June 2025: 15.00% Strong Buy, 50.00% Buy, 35.00% Hold, 0% Sell, 0% Strong Sell.
  • May 2025: 20.00% Strong Buy, 50.00% Buy, 30.00% Hold, 0% Sell, 0% Strong Sell.
  • April 2025: 20.00% Strong Buy, 45.00% Buy, 35.00% Hold, 0% Sell, 0% Strong Sell.

What is Revvity’s EPS forecast?

Revvity's average annual EPS forecast for its fiscal year ending in December 2025 is $4.98, marking a 116.52% increase from the reported $2.3 in 2024. Estimates for the following years are $5.59 in 2026, $6.21 in 2027, and $6.64 in 2028.

What is Revvity’s revenue forecast?

Revvity's average annual revenue forecast for its fiscal year ending in December 2025 is $2.86B, reflecting a 3.82% increase from the reported $2.76B in 2024. The forecast for 2026 is $3.05B, followed by $3.23B for 2027, and $3.3B for 2028.

What is Revvity’s net income forecast?

Revvity's net income forecast for the fiscal year ending in December 2025 stands at $627.36M, representing an 132.02% increase from the reported $270.38M in 2024. Projections indicate $675M in 2026, $776.55M in 2027, and $828.5M in 2028.